The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Sep. 01, 2020

Filed:

Aug. 28, 2017
Applicants:

Jcr Pharmaceuticals Co., Ltd., Ashiya-shi, JP;

National University Corporation Kobe University, Kobe-shi, JP;

National University Corporation Chiba University, Chiba-shi, JP;

Inventors:

Susumu Seino, Kobe, JP;

Kenji Sugawara, Kobe, JP;

Ichiro Mori, Kobe, JP;

Akio Matsumoto, Chiba, JP;

Yoshie Reien, Chiba, JP;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07D 337/06 (2006.01); C07C 337/06 (2006.01); C07C 281/06 (2006.01); A61P 3/10 (2006.01); A61K 31/17 (2006.01); A61K 31/175 (2006.01); A61P 3/08 (2006.01); A61K 9/00 (2006.01);
U.S. Cl.
CPC ...
C07C 337/06 (2013.01); A61K 9/0053 (2013.01); A61K 31/17 (2013.01); A61K 31/175 (2013.01); A61P 3/08 (2018.01); A61P 3/10 (2018.01); C07C 281/06 (2013.01);
Abstract

A nobel therapeutic agent for diabetes which can suppress occurrence of side effects such as persistent hypoglycemia is provided. The active ingredient is a derivative of 1,1-diphenylsemicarbazide or 1,1-diphenylthiosemicarbazide. In particular, the active ingredient is a derivative of 1,1-diphenyl-4-cyclohexyl-semicarbazide or 1,1-diphenyl-4-cyclohexyl-thiosemicarbazide exhibiting hypoglycemic action when orally administered.


Find Patent Forward Citations

Loading…